Clinical Trials List
2019-01-01 - 2027-05-27
Phase III
Recruiting9
ICD-9185
Malignant neoplasm of prostate
-
Trial Applicant
Johnson & Johnson
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Hung-Lung Ke Division of Urology
- 阮雍順 Division of Urology
- Shu-Pin Huang Division of Urology
- Sheng-Chen Wen Division of Urology
- Yung-Chin Lee Division of Urology
- Hsiang Ying Lee Division of Urology
- Ching-Chia Li Division of Urology
- 黃俊農 Division of Urology
- 李政學 Division of Urology
- Tsung-Yi Huang Division of Urology
- Tsu-Ming Chien Division of Urology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Chi-Ping Huang Division of Urology
- Che-Hung Lin Division of Hematology & Oncology
- Chi-Rei Yang Division of Urology
- 陳冠亨 Division of Urology
- Wei-Ching Lin Division of Radiology
- Po-Jen Hsiao Division of Urology
- Hsi-Chin Wu Division of Hematology & Oncology
- Su-Peng Yeh Division of Hematology & Oncology
- Ching-Chan Lin Division of Hematology & Oncology
- 謝德鈞 Division of Nuclear Medicine
- Yi-Huei Chang Division of Urology
- Yu-De Wang Division of Urology
- Po-Fan Hsieh Division of Urology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 陳威任 Division of Urology
- Tzu-chun Wei Division of Urology
- William Huang Division of Urology
- Chih-Chieh Lin Division of Urology
- 沈書慧 Division of Urology
- Yi-Hsiu Huang Division of Urology
- 朱力行 Division of Urology
- Yen-Hwa Chang Division of Urology
- Yu-Hua Fan Division of Urology
- Tzu-Ping Lin Division of Urology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Yung-Chang Lin Division of Hematology & Oncology
- Hong-Cheng Gan Division of Hematology & Oncology
- Jing-Ren Tseng Division of Nuclear Medicine
- Rita cheng Division of Hematology & Oncology
- I-hung Shao Division of Hematology & Oncology
- 黃成之 Division of Radiology
- 劉忠一 Division of Hematology & Oncology
- Po-Jung Su Division of Hematology & Oncology
- 張英勛 Division of Hematology & Oncology
- Kai-Jie Yu Division of Hematology & Oncology
- 范綱行 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- YU-CHUAN LU Division of Hematology & Oncology
- CHING-CHU LU Division of Hematology & Oncology
- - - Division of Hematology & Oncology
- YEN-HENG LIN Division of Hematology & Oncology
- CHUNG-HSIN CHEN Division of Hematology & Oncology
- JHE-CYUAN GUO Division of Hematology & Oncology
- Yeong-Shiau Pu Division of Hematology & Oncology
- Ying-Chun Shen Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Chia-Yen Lin Division of Urology
- Cheng-Kuang Yang Division of Urology
- 裘坤元 Division of Urology
- 洪啟峰 Division of Urology
- 王樹吉 Division of Urology
- Cheng-Che Chen Division of Urology
- 盧嘉文 Division of Urology
- 熊小澐 Division of Radiology
- Chuan-Shu Chen Division of Urology
- 洪晟鈞 Division of Urology
- Jian-Ri Li Division of Urology
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
36 participants
-
Global
1100 participants
